Impact of Preoperative Clopidogrel Administration on Perioperative Blood Loss and Transfusion Requirements in Patients Undergoing Coronary Artery Bypass Graft Surgery
Background: Clopidogrel is an adenosine-5' diphosphate (ADP) receptor antagonist that eventually inhibits platelet aggregation. It is used concomitantly with percutaneous coronary interventions and in patients with acute coronary diseases. This study was conducted to determine the effects of pr...
Main Authors: | Keyvan Bagheri, Seyed Mohammad Reza Safavi, Azim Honarmand, Mohammadali Attari, Masoud Nazem, Javad Ahmadi, Mehdi Khazaei |
---|---|
Format: | Article |
Language: | fas |
Published: |
Isfahan University of Medical Sciences
2014-03-01
|
Series: | مجله دانشکده پزشکی اصفهان |
Subjects: | |
Online Access: | http://jims.mui.ac.ir/index.php/jims/article/view/3245 |
Similar Items
-
Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel
by: Alexander Kurian S, et al.
Published: (2003-05-01) -
Transfusion associated in-hospital mortality and morbidity in isolated Coronary Artery Bypass Graft surgery
by: Salehiomran Abbas, et al.
Published: (2009-09-01) -
Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial
by: Rafiq Sulman, et al.
Published: (2012-04-01) -
Effect of anti-platelet therapy on peri-operative blood loss in patients undergoing off-pump coronary artery bypass grafting
by: Samir Kapoor, et al.
Published: (2022-01-01) -
The effect of low- dose tranexamic acid on postoperative blood loss in patients treated with clopidogrel and aspirin
by: Nadia Banihashem, et al.
Published: (2019-03-01)